info@quantimol.com - 1 (800) 821-7314 - Research Use Only - B2B & B2G Only - Not For Private Use
SKU:QM-0141495-01
Couldn't load pickup availability
DRF-1042 is an orally active derivative of Camptothecin. DRF-1042 acts to inhibit DNA topoisomerase I. DRF-1042 shows good anticancer activity against a panel of human cancer cell lines including multi-agent resistance (MDR) phenotype[1][2].
[200619-13-2]
C22H20N2O6
408.4
O=C1[C@](CC)(C2=C(C(N3C(C4=CC5=CC=CC=C5N=C4C3=C2)OCCO)=O)CO1)O
ADC Payload; Topoisomerase
98.06
DMSO : 50 mg/mL (ultrasonic)
-20°C (Powder, stored under nitrogen)
Blue Ice
H301
Loading...
Total items
Product subtotal
DRF-1042 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.